Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Apimeds Pharmaceuticals US, Inc.

NYSE: APUS · Life Sciences · 5 alerts · CIK 1894525

Share price
$2.04Close, Nov 16
Market cap
$3.77M
Shares outstanding
1.85MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Apimeds Pharmaceuticals US, Inc. filings on SEC EDGAR ↗

4:10 PM ET 10-Q
Financial Results

Apimeds Pharmaceuticals US Q3 2026 Results: Turns Profitable, Net Income $33.6M

Apimeds Pharmaceuticals US, Inc. reported a net loss of $21.6 million for the nine months ended September 30, 2026, compared to a $4.8 million loss in the prior year. The company transitioned its operations, recording its first software development revenue of $2.48 million while managing a significant digital asset portfolio valued at $142.4 million.

Key figure
Net income $33.6M

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.